Adhera Therapeutics IncOOTC ATRX Stock Report

Adhera Therapeutics, Inc. is an emerging specialty biotech company, which is in the process of evaluating its focus including a return to drug discovery and development. The company is headquartered in Wake Forest, North Carolina. The firm provides a DyrctAxess technology platform, which offers enhanced efficiency, control, and information to empower patients, physicians, and manufacturers to help achieve optimal care. The firm's Total Care platform provides direct prescription delivery from the manufacturer to the patient to ensure fulfilment, ease of use for patients and physicians on all types of devices and mobile applications, real-time monitoring, and communications between patients and physicians, and automatic patient reminders and refills. The firm's licensed products including the patents and related intellectual property from Melior Pharmaceuticals II, LLC are MRL 1019, and MRL 1023. MRL 1019 is used for the treatment of Parkinson's disease (PD) and MRL 1023 is used for the treatment of type 1 diabetes, non-alcoholic steatohepatitis (NASH), and pulmonary inflation.